Anti-Lamin A + Lamin C antibody [EPR4519(2)]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(15 Publications)
Rabbit Recombinant Monoclonal Lamin-A/C antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Rat samples. Cited in 15 publications.
View Alternative Names
LMN1, LMNA, Prelamin-A/C
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
ab169532 showing +ve staining in Human normal kidney tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
Immunohistochemical analysis of paraffin-embedded Human skin tissue labeling Lamin A + C with ab169532 at 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
ab169532 showing +ve staining in Human normal brain tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
ab169532 showing +ve staining in Human normal colon tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
ab169532 showing +ve staining in Human normal tonsil tissue.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
Immunohistochemical analysis of paraffin-embedded Human uterus tissue labeling Lamin A + C with ab169532 at 1/250 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
Lanes 1 - 4 : Merged signal (red and green). Green - ab169532 observed at 70-75 kDa. Red - loading control, ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab169532 was shown to react with LMNA in wild-type HAP1 cells in Western blot. Loss of signal was observed when LMNA knockout sample was used. HAP1 wild-type and LMNA knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% Milk in TBS-T (0.1% Tween®) before incubation with ab169532 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 5000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (ab169532) at 1/5000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 20 µg
Lane 2:
LMNA knockout HAP1 cell lysate at 20 µg
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
HepG2 cell lysate at 20 µg
Predicted band size: 74 kDa
Observed band size: 70-75 kDa
false
- WB
Lab
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
Blocking and Diluting buffer 5% NFDM /TBST
65-74 kDa : full length;
45-50 kDa : cleavage forms
All lanes:
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (ab169532) at 1/5000 dilution
Lane 1:
Mouse brain tissue lysate at 10 µg
Lane 2:
Mouse heart tissue lysate at 10 µg
Lane 3:
Mouse kidney tissue lysate at 10 µg
Lane 4:
Mouse spleen tissue lysate at 10 µg
Lane 5:
Rat brain tissue lysate at 10 µg
Lane 6:
Rat heart tissue lysate at 10 µg
Lane 7:
Rat kidney tissue lysate at 10 µg
Lane 8:
Rat spleen tissue lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/2000 dilution
Predicted band size: 74 kDa
Observed band size: 74 kDa
false
Exposure time: 30s
- WB
Unknown
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
All lanes:
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (ab169532) at 1/10000 dilution
Lane 1:
PC-12 cell lysate at 10 µg
Lane 2:
THP-1 cell lysate at 10 µg
Lane 3:
HeLa + Staurosporine cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Secondary
All lanes:
HRP labeled goat anti-rabbit at 1/2000 dilution
Predicted band size: 74 kDa
false
- WB
CiteAb
Western blot - Anti-Lamin A + Lamin C antibody [EPR4519(2)] (AB169532)
Lamin A + Lamin C western blot using anti-Lamin A + Lamin C antibody [EPR4519(2)] ab169532. Publication image and figure legend from Zhang, Y., Li, D., et al., 2018, Cell Death Dis, PubMed 29970890.
ab169532 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab169532 please see the product overview.
Identification of the non-cytotoxic concentration of ZLDI-8 in MHCC97-H cells.a Molecular docking for the interaction between ZLDI-8 and ADAM-17. b MHCC97-H cells were treated with indicated concentration of ZLDI-8, and the inhibition rates were calculated. c The effect of 1 μmol/L or 3 μmol/L ZLDI-8 was examined at each time point. d MHCC97-H, which were treated with indicated concentration of ZLDI-8, were fractionated into cytoplasmic and nuclear fractions. The fractions were detected with anti-NICD antibody and ADAM-17 antibodies. β-actin was chosen as a cytoplasmic marker and Lamin A/C was the nuclear indicator. e, f MHCC97-H cells, which were treated with 1 μmol/L ZLDI-8, were examined to detect the protein level of anti-apoptosis/pro-survival (e) or EMT (f) related regulators
false
Related conjugates and formulations (1)
-
Anti-Lamin A + Lamin C antibody [EPR4519(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Lamin A/C proteins play a role in maintaining nuclear stability chromosome organization and gene regulation. They are part of a complex network within the nuclear lamina that includes interactions with proteins and DNA. Lamin A with a molecular weight distinct from other lamins participates in assembling this supportive matrix and contributes to DNA maintenance and repair processes. Their interaction with chromatin and gene expression regulation emphasizes their influence on important cellular functions.
Pathways
Lamin A/C proteins engage in the mechanosensory signaling and DNA damage response pathways. They interact with pathways involving the nuclear envelope structure and have connections to proteins like emerin and nuclear actin. Lamin A's role in these pathways supports its involvement in responding to mechanical stress and preserving genomic integrity highlighting its integration with these cellular processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Nature cell biology 27:438-448 PubMed39984653
2025
Applications
Unspecified application
Species
Unspecified reactive species
BioFactors (Oxford, England) 50:1113-1133 PubMed38655699
2024
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 17:227-242 PubMed38533131
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37830614
2023
Applications
Unspecified application
Species
Unspecified reactive species
Human molecular genetics 32:2950-2965 PubMed37498175
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell metabolism 35:535-549.e7 PubMed36681077
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed36611846
2022
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells translational medicine 11:539-551 PubMed35325230
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34943861
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neurogenetics 22:297-312 PubMed34345994
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com